Collectively, these genetic variants and SNPs may abolish, create, or modify the binding sites for transcription factors within the SIRT1 gene promoter, which then alter SIRT1 levels, contributing to the T2D development. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.